Silence Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLN and other ETFs, options, and stocks.

About SLN

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. 

CEO
Craig Allen Tooman
CEOCraig Allen Tooman
Employees
116
Employees116
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
1994
Founded1994
Employees
116
Employees116

SLN Key Statistics

Market cap
227.90M
Market cap227.90M
Price-Earnings ratio
-3.05
Price-Earnings ratio-3.05
Dividend yield
—
Dividend yield—
Average volume
47.15K
Average volume47.15K
High today
$5.29
High today$5.29
Low today
$4.81
Low today$4.81
Open price
$5.10
Open price$5.10
Volume
31.33K
Volume31.33K
52 Week high
$20.48
52 Week high$20.48
52 Week low
$1.97
52 Week low$1.97

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
0%
Sell
14.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.